The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.

Published

Conference Paper

Full Text

Link to Item

Duke Authors

Kirk, Allan Douglas

Cited Authors

Hoffmann, SC; Kampen, RL; Pearl, JP; Hale, DA; Jacobson, LM; Kleiner, DE; Mannon, RB; Muehrer, RJ; Swanson, SJ; Becker, BN; Kirk, AD

Published Date

January 1, 2004

Published In

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Volume / Issue

4 /

Start / End Page

332 - 332

Published By

BLACKWELL MUNKSGAARD

Pages

1

International Standard Serial Number (ISSN)

1600-6135

Conference Name

American Transplant Congress

Conference Location

Boston, MA

Conference Start Date

May 14, 2004

Conference End Date

May 19, 2004